Chemical synthesis of (S)-spiro(estradiol-17,2′-[1,4]oxazinan)- 6′-one derivatives bearing two levels of molecular diversity

European Journal of Organic Chemistry

Volumn , Issue 14, 2008, Pages 2446-2453

  Rouillard, François ^a   Roy, Jenny ^a   Poirier, Donald ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Amino acids; Enzyme inhibitors; Estradiol derivatives; Lactones; Steroids

Indexed keywords

EID: 53749103093     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200701077     Document Type: Article

References (48)

1. a) V. Luu-The, J. Steroid Biochem. Mol. Biol. 2001, 76, 143-151;
2. b) F. Labrie, V. Luu-The, S. X. Lin, J. Simard, M. El-Alfy, G. Pelletier, J. Mol. Endocr. 2000, 25, 1-16;
3. c) F. Labrie, V. Luu-The, S. X. Lin, J. Simard, C. Labrie, TEM 2000, 11, 421-427;
4. d) N. Moghrabi, S. Andersson, TEM 1998, 9, 265-270;
5. e) F. Labrie, V. Luu-The, S. X. Lin, J. Simard, C. Labrie, R. Breton, Steroids 1997, 62, 148-158.
6. C. Martel, E. Rheaume, M. Takahashi, C. Trudel, J. Couet, V. Luu-The, J. Simard, F. Labrie, J. Steroid Biochem. Mol. Biol. 1992, 41, 597-603.
7. a) H. Peltoketo, V. Isomaa, O. Maentausta, R. Vihko, J. Mol. Endocr. 1999, 23, 1-11;
8. b) V. Luu-The, Y. Zhang, D. Poirier, F. Labrie, J. Steroid Biochem. Mol. Biol. 1995, 55, 581-587.
9. a) D. Poirier, Curr. Med. Chem. 2003, 10, 453-477;
10. b) D. Poirier, R. Maltais, Mini-Rev. Med. Chem. 2006, 6, 37-52;
11. c) D. Poirier, P. Bydal, M. R. Tremblay, K. M. Sam, V. Luu-The, Mol. Cell Endocrinol. 2001, 171, 119-128;
12. d) M. R. Tremblay, D. Poirier, J. Steroid Biochem. Mol. Biol. 1998, 66, 179-191.
13. a) S. Auger, V. Luu-The, K. M. Sam, D. Poirier, Bioorg. Med. Chem. Lett. 1994, 4, 2045-2048;
14. b) K. M. Sam, F. Labrie, D. Poirier, Eur. J. Med. Chem. 2000, 35, 217-225.
15. a) K. M. Sam, S. Auger, V. Luu-The, D. Poirier, J. Med. Chem. 1995, 38, 4518-4528;
16. b) M. R. Tremblay, V. Luu-The, G. Leblanc, P. Noel, E. Breton, F. Labrie, D. Poirier, Bioorg. Med. Chem. 1999, 7, 1013-1023.
17. P. Bydal, S. Auger, D. Poirier, Steroids 2004, 69, 325-342.
18. W. Qiu, M. Zhou, M. Mazumdar, A. Azzi, D. Ghanmi, V. Luu-The, F. Labrie, S. X. Lin, J. Biol. Chem. 2007, 282, 8368-8379.
19. a) F. Labrie, A. Belanger, S. Gauthier, V. Luu-The, Y. Merand, D. Poirier, L. Provencher, S. M. Singh (Endorecherche Inc., Canada), US 6541463, 2003;
20. b) P. Bydal, M.Sc. Thesis, University Laval, Québec (Québec), Canada, 1997, ch. 3 and 4, pp. 98-153.
21. a) C. E. Cook, R. C. Corley, M. E. Wall, J. Org. Chem. 1968, 33, 2789-2793;
22. b) K. Ponsold, M. Hubner, H. Kasch, I. Noack, Z. Chem. 1971, 11, 106-107;
23. c) M. Hubner, I. Noack, J. Prakt. Chem. 1972, 314, 667-668;
24. d) T. Arunachalam, E. Caspi, J. Org. Chem. 1981, 46, 3415-3420;
25. e) J. L. Zhang, H. B. Zhou, J. S. Huang, C. M. Che, Chem. Eur. J. 2002, 8, 1554-1562;
26. f) M. Salman, B. R. Reddy, P. Delgado, P. L. Stotter, L. C. Fulcher, G. C. Chamness, Steroids 1991, 56, 375-387;
27. g) S. Top, H. El Hafa, A. Vessieres, J. Quivy, J. Vaissermann, D. W. Hughes, M. J. McGlinchey, J. P. Mornon, E. Thoreau, G. Jaouen, J. Am. Chem. Soc. 1995, 117, 8372-8380.
28. a) T. L. Feviq, J. A. Katzenellenbogen, J. Org. Chem. 1987, 52, 247-251;
29. b) M. R. Tremblay, S. Auger, D. Poirier, Synth. Commun. 1995, 25, 2483-2495;
30. c) D. Poirier, R. P. Boivin, M. R. Tremblay, M. Berube, W. Qiu, S. X. Lin, J. Med. Chem. 2005, 48, 8134-8147.
31. R. Maltais, M. R. Tremblay, D. Poirier, J. Comb. Chem. 2000, 2, 604-614.
32. M. Chini, P. Crotti, F. J. Macchia, J. Org. Chem. 1991, 56, 5939-5942.
33. a) R. Maltais, V. Luu-The, D. Poirier, Bioorg. Med. Chem. 2001, 9, 3001-3011;
34. b) R. Maltais, V. Luu-The, D. Poirier, J. Med. Chem. 2002, 45, 640-653.
35. a) J. Iqbal, A. Pandey, Tetrahedron Lett. 1990, 31, 575-576;
36. b) G. Sekar, V. K. Singh, J. Org. Chem. 1999, 64, 287-289;
37. c) L. R. Reddy, M. A. Reddy, N. Bhanumathi, K. R. Rao, Synlett 2000, 3, 339-340.
38. D. Thibeault, D. Poirier, Synlett 2003, 8, 1192-1194.
39. P. Bydal, K. M. Sam, D. Poirier, Steroids 1996, 61, 349-353.
40. a) J. D. Pelletier, F. Labrie, D. Poirier, Steroids 1994, 59, 536-547;
41. b) P. Dionne, D. Poirier, Steroids 1995, 60, 830-836.
42. T. D. W. Claridge, Tetrahedron Organic Chemistry Series Vol. 19: High-Resolution NMR Techniques in Organic Chemistry (Eds.: J. E. Baldwin, R. M. Williams), Pergamon, New York, 1999, pp. 382.
43. CCDC-676120 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
44. a) G. M. Allan, H. R. Lawrence, J. Cornet, C. Bubert, D. D. Fischer, N. Vicker, A. Smith, H. J. Tutill, A. Purohit, J. M. Day, M. F. Mahon, M. J. Reed, B. V. L. Potter, J. Med. Chem. 2006, 49, 1325-1345;
45. b) N. Vicker, H. R. Lawrence, G. M. Allan, C. Bubert, A. Smith, H. J. Tutill, A. Purohit, J. M. Day, M. F. Mahon, M. J. Reed, B. V. L. Potter, ChemMedChem 2006, 1, 464-481;
46. c) J. Messinger, H. H. Thole, B. Husen, B. J. Van Steen, G. Schneider, J. B. E. Hulshof, P. Koskimies, N. Johansson (Solvay pharmaceuticals GMBH), WO 2005/047303, 2005;
47. d) D. Poirier, R. Maltais, Mini-Rev. Med. Chem. 2006, 6, 37-52;
48. e) R. Maltais, M. R. Tremblay, L. C. Ciobanu, D. Poirier, J. Comb. Chem. 2004, 6, 443-456.